Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

A Clinical Trial to Evaluate the Long-term Safety and Durability of Efficacy of BI 3720931, an Inhaled Lentiviral Vector Gene Therapy, After Single Dose Administration in a Previous Clinical Trial, in People With Cystic Fibrosis Rolled-over From a Previous Clinical Trial With BI 3720931 (Lenticlair-ON)

Next Previous
Trial Profile

A Clinical Trial to Evaluate the Long-term Safety and Durability of Efficacy of BI 3720931, an Inhaled Lentiviral Vector Gene Therapy, After Single Dose Administration in a Previous Clinical Trial, in People With Cystic Fibrosis Rolled-over From a Previous Clinical Trial With BI 3720931 (Lenticlair-ON)

Status: Recruiting
Phase of Trial: Phase I/II

Latest Information Update: 23 Nov 2025

Price :
$35 *
Note:
  • Adis is an information provider.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
  • A link to download a PDF version of the trial profile will be included in your email receipt.

At a glance

  • Drugs BI 3720931 (Primary)
  • Indications Cystic fibrosis
  • Focus Adverse reactions
  • Acronyms Lenticlair-ON
  • Sponsors Boehringer Ingelheim

Most Recent Events

  • 28 Oct 2025 Planned End Date changed from 17 Jul 2048 to 11 Aug 2048.
  • 28 Oct 2025 Planned primary completion date changed from 17 Jul 2048 to 11 Aug 2048.
  • 26 Aug 2025 Planned End Date changed from 18 Sep 2047 to 17 Jul 2048.

You need to be a logged in or subscribed to view this content

Request demo (opens in a new window)
If your organization or you do not have a subscription, try one of the following: If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top